ApprovalTrail

Approval · Notice of Compliance 30517 · 2023

TORADOL: Notice of Compliance 30517

Issued April 14, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
30517
Date
April 14, 2023
Company
AA Pharma Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Safety Updates to the Product Monograph (PM).

Products in this notice

BrandDINStatus today
TORADOLNot yet assigned—

Medicinal ingredients